Irritable bowel syndrome
Authors:
Jiří Dolina 1
; A. Hep 2; M. Mišejková 2
Authors‘ workplace:
Endoskopické centrum FN Brno, pracoviště Bohunice, přednosta prim. MUDr. Jiří Dolina, Ph. D.
1; Interní gastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Aleš Hep, CSc.
2
Published in:
Vnitř Lék 2011; 57(9): 681-683
Category:
65th birthday Mudr. Jany Laciné and and 60th birthday Milana Tržila
Overview
Irritable bowel syndrome is a frequent functional disorder of gastrointestinal tract. Its high incidence represents an important socioeconomic concern. The diagnosis of irritable bowel syndrome is indirect and requires exclusion of an organic lesion within as well as outside the gastrointestinal tract. No algorithms – so called treatment guidelines – are available for pharmacological or non-pharmacological treatment of the irritable bowel syndrome. Long-term and comprehensive care of patients with functional diseases is an important component of the management of patients with irritable bowel syndrome.
Key words:
irritable bowel syndrome – Rome criteria III
Sources
1. Lukáš K, Hep A. Římská klasifikace III (2006). Čes Slov Gastroent Hepatol 2007; 61 : 39.
2. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. In: Drossman DA, Corazziari E, Delvaux M et al (eds). Rome III – The functional gastrointestinal disorders. Allen Press, Inc., Lawrence, KS 2006 : 487–556.
3. Longstreth GF. Definition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am 2005; 34 : 173–187.
4. Beneš Z. Kolorektální karcinom a nespecifické střevní záněty. Praktický lékař 2007; 87 : 624–626.
5. Ehrmann J. Záněty střev a dráždivý tračník. Interní Med Pro Praxi 2009; 11 : 71.
6. Lukáš K et al. Funkční poruchy trávicího traktu. Praha: Grada 2003 : 198 s.
7. O‘Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128 : 541–551.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2011 Issue 9
-
All articles in this issue
- Criteria for perioperative risk evaluation – non-cardiac surgery
- Current perspective of treating hypertension in pregnancy
- New antithrombotics in the prevention of venous thromboembolia and new anti-platelet drugs
- Targeted biological treatment of solid tumours
- Proteinuria in primary care
- The importance of antihypertensive therapy in subclinical brain damage
- Plypharmacy and drug interactions
- Is there any relation between diabetes tharapy and cancer risk?
- Combined exercise training in men with metabolic syndrome after acute coronary event
- Diagnostic of secondary hypertension in clinical practice
- FARIM – FARmakoterapie po Infarktu Myokardu (Post-Myocardial Infarction Pharmacotherapy study)
- Thyreopathy in primary care
- Czech angiology and its transformation
- Irritable bowel syndrome
- Biological treatment in dermatology – psoriasis
- Prokinetic agents – their contribution to practice of gastroenterology
- Liver diseases in internal medicine outpatient clinics
- Arrhythmology today: risks associated with anti-arrhythmic therapy in an internal medicine outpatient clinic
- Treating stable chronic obstructive pulmonary disease (COPD) and its potential cardiovascular risks (a basic overview)
- Internal Medicine
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Proteinuria in primary care
- Prokinetic agents – their contribution to practice of gastroenterology
- Plypharmacy and drug interactions
- Thyreopathy in primary care